{
    "nctId": "NCT00083044",
    "briefTitle": "Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy",
    "officialTitle": "Surrogate Endpoints in Prevention Studies and Ductal Lavage",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Cell morphology and protein expression of breast epithelial cells in duct lavage samples as a marker of tamoxifen effect",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Meets 1 of the following criteria:\n\n  * Diagnosis of small invasive breast cancer\n  * Diagnosis of ductal or lobular carcinoma in situ of the breast\n  * At high risk for breast cancer (5-year Gail model risk of \\> 1.6%)\n* Eligible for tamoxifen therapy\n* No plans for adjuvant chemotherapy\n* Prior unilateral early breast cancer allowed\\* NOTE: \\*Only the unaffected breast will be examined during this study\n* Hormone-receptor status:\n\n  * Estrogen receptor-positive (in patients with small invasive breast cancer)\n\nPATIENT CHARACTERISTICS:\n\nAge\n\n* 18 to 64\n\nSex\n\n* Female\n\nMenopausal Status\n\n* Premenopausal or postmenopausal\n\nPerformance status\n\n* Not specified\n\nLife expectancy\n\n* Not specified\n\nHematopoietic\n\n* Not specified\n\nHepatic\n\n* Not specified\n\nRenal\n\n* Not specified\n\nCardiovascular\n\n* No prior venous thromboembolism\n\nOther\n\n* At least 12 months post-partum\n* Not pregnant\n* Not nursing within the past 12 months\n* No known allergy to lidocaine, prilocaine, or bupivacaine\n* No uterine hyperplasia or polyps\n* No other contraindication to tamoxifen\n\nPRIOR CONCURRENT THERAPY:\n\nBiologic therapy\n\n* Not specified\n\nChemotherapy\n\n* See Disease Characteristics\n* More than 6 months since prior chemotherapy\n\nEndocrine therapy\n\n* Concurrent hormone-replacement therapy allowed\n* Prior tamoxifen or raloxifene allowed provided treatment duration was no more than 6 months\n* At least 1 year since prior raloxifene\n\nRadiotherapy\n\n* Not specified\n\nSurgery\n\n* Not specified",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}